- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04911088
Electromyographic Calibration Guided by Depth of Anesthesia (CELESTE)
Does Calibration of Electromyography Guided by State Entropy Improve Measurement Precision
Study Overview
Status
Conditions
Detailed Description
Neuromuscular monitoring is used to document neuromuscular function intra-operatively. Failure to restore neuromuscular function prior to extubation results in residual neuromuscular blockade which is associated with increased postoperative morbidity and mortality. It is essential to document baseline neuromuscular function before administration of the neuromuscular blocking agent. However, during anesthesia induction, neuromuscular monitoring is rarely calibrated due to its time-consuming nature coinciding with the patients' loss of consciousness.
The CELESTE trial is a randomized, prospective, observational proof-of-concept study. We plan to enroll sixty adult participants scheduled for elective non-cardiac surgery requiring general anesthesia with moderate neuromuscular blockade. Participants will be randomized into three electromyography (EMG) calibration groups: based on state entropy ("depth of anesthesia"), group 1 will receive "analgesic calibration", group 2 "sedated calibration", and group 3 "no calibration". Participants will be randomly allocated to receive calibration at a certain depth of anesthesia. All participants will receive a standard EMG performed on the contralateral arm. Standard EMG will be calibrated at state entropy of 50.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Baden-Wurttemberg
-
Ulm, Baden-Wurttemberg, Germany, 89073
- University Hospital Ulm
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- signed informed written consent
- BMI 17.5-30 kg/m^2
- ASA <= 3
- supine positioning during surgery with intraoperative access to both arms
- absence of allergy to muscle relaxants and reversal agents
- absence of neuromuscular disease
Exclusion Criteria:
- ambulatory patients for whom discharge is planned within 12 hours of anaesthesia
- patients undergoing minor surgical
- procedures scheduled outside the operating room
- patients who are endotracheally intubated prior to surgery
- pregnancy
- indication for rapid sequence induction
- patients undergoing arm surgery
- patients with preceding injuries impairing muscle or nerve function of the arm (e.g., finger amputation)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Analgesic calibration
Participants will receive calibration of electromyography at state entropy of 90.
|
|
Sedated calibration
Calibration will be started at state entropy of 70.
|
|
No calibration
Participants will not receive calibration of electromyography.
Measurements will start simultaneously to the standard electromyography with a default current of 60mA at state entropy of 50.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Precision of Train-of-four measurements
Time Frame: intraoperative
|
repeatability coefficient
|
intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recall of calibration
Time Frame: postoperative day 1
|
postoperative day 1
|
|
|
Discomfort with calibration
Time Frame: postoperative day 1
|
postoperative day 1
|
|
|
Tolerance interval of Train-of-four ratios
Time Frame: intraoperative
|
intraoperative
|
|
|
Agreement of EMG calibration group Train-of-four and standard Train-of-four
Time Frame: intraoperative
|
Agreement of both calibration group EMG and standard EMG regarding the decision whether complete neuromuscular recovery is given based on a Train-of-four ratio of >0.9 or >0.95, respectively.
|
intraoperative
|
|
Time difference between calibration group Train-of-four and standard Train-of-four to complete recovery
Time Frame: intraoperative
|
Time difference between calibration group EMG and the standard EMG reaching a Train-of-four ratio >0.9 or >0.95, respectively.
|
intraoperative
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Manfred Blobner, MD PhD, Department of Anesthesiology and Intensive Care Medicine, University of Ulm, Ulm, Germany.
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CELESTE-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.